CTOs on the Move

Autolus

www.autolus.com

 
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.autolus.com
  • 805 King Farm Boulevard Suite 550
    Rockville, MD USA 20850
  • Phone: n/a

Executives

Name Title Contact Details
Mike Sonnenberg
 Vice President Profile
Shasta Rizzi
 Associate Director, IT Business Analyst Profile

Similar Companies

Daiichi Sankyo

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets.

Color

Color`s mission is to help people lead the healthiest lives that science and medicine can offer. We launched in April 2015 with a simple, affordable genetic test to help people understand their risk for hereditary cancer. In 2017, we added coverage for hereditary heart conditions.

Immunitas Therapeutics

Immunitas Therapeutics is a single cell genomics-based drug discovery company.

Wax-it Histology Services

Wax-it Histology Services Inc. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AmProx

AmProx is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.